COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,726 Articles (22,502 medRxiv, 8,224 bioRxiv)

Most recent first Previous |  Page 1066: Articles 10651-10660  | Next

ROLE OF BODY MASS AND PHYSICAL ACTIVITY IN AUTONOMIC FUNCTION MODULATION ON POST-COVID-19 CONDITION: AN OBSERVATIONAL SUBANALYSIS OF FIT-COVID STUDY
Freire, A. P. F., Santos de Lira, F., von Ah Morano, A. E., Pereira, T., Coelho Silva, M.-J., Caseiro, A., Destro Christofaro, D. G., Marchioto, O., Pires Dorneles, G., Aurino Pinho, R., Spolador de Alencar Silva, B.
10.1101/2021.11.17.21266473 — Posted: 2021-11-21
Antibody titers before and after booster doses of SARS-CoV-2 mRNA vaccines in healthy adults
Demonbreun, A. R., Sancillo, A., Vaught, L. A., Reiser, N. L., Pesce, L., McNally, E. M., McDade, T. W.
10.1101/2021.11.19.21266555 — Posted: 2021-11-21 Discussion: Onsite
Patient experience with healthcare: Feedback for a Post COVID-19 clinic at a tertiary care center in rural area
Garg, A., Subramain, M., Barlow, P. B., Garvin, L., Hoth, K. F., Dukes, K., Hoffman, R. M., Comellas, A. P.
10.1101/2021.11.20.21266640 — Posted: 2021-11-21
Race-Specific, U.S. State-Specific COVID-19 Vaccination Rates Adjusted for Age
Wrigley-Field, E., Berry, K. M., Persad, G.
10.1101/2021.11.19.21266612 — Posted: 2021-11-21
Very high relative seroprevalence of anti-SARS-CoV-2 antibodies among communities in Bangui, Central African Republic
Manirakiza, A., Malaka, C., Yambiyo, B. M., Diemer, S. C. H., Longo, J. d. D., Namsenei, J., Coti-Reckoundji, C. S. G., Bouhouda, M., Darnycka, B. M. R., Roungou, J. B., Komas, N. P., Gresenguet, G., Vernet, G., Vernet, M.-A., Nakoune, E.
10.1101/2021.11.18.21266496 — Posted: 2021-11-21
SeroTracker-ROB: reproducible decision rules for risk of bias assessment of seroprevalence studies
Bobrovitz, N., Noel, K. C., Li, Z., Cao, C., Deveaux, G., Selemon, A., Yanes Lane, M., Yan, T., Arora, R. K.
10.1101/2021.11.17.21266471 — Posted: 2021-11-21
Failure of Concentric Regulatory Zones to Halt the Spread of COVID-19 in South Brooklyn, New York: October-November 2020
Harris, J.
10.1101/2021.11.18.21266493 — Posted: 2021-11-21
Protective characteristics of COVID-19 convalescent and post-vaccination IgG antibodies
Klegerman, M. E., Peng, T., Seferovich, I., Rahbar, M. H., Hessabi, M., Tahanan, A., Wanger, A., Grimes, C. Z., Ostrosky-Zeichner, L. Z., Koster, K., Cirillo, J. D., Abeydeera, D., De Lira, S., McPherson, D. D.
10.1101/2021.11.19.21266547 — Posted: 2021-11-21
Effectiveness of Vaccination Against Reported SARS-CoV-2 Infection in United States Coast Guard Personnel Between May and August 2021: A Time-Series Analysis
Iskander, J., Frost, J. K., Russell, S., Ahluwalia, J., Ward, E., Steiner, S., Thomas, D., Michaud, P.
10.1101/2021.11.19.21266537 — Posted: 2021-11-21
Risk factors for workplace bullying, severe psychological distress, and suicidal ideation during the COVID-19 pandemic: a nationwide internet survey for the general working population in Japan
Tsuno, K., Tabuchi, T.
10.1101/2021.11.18.21266501 — Posted: 2021-11-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).